Diagnosis and Care Planning Elements of Value in Oncology Care Value Stream Process Flow Considerations for Patients, Employer/Payers, Providers and Private Equity May 24, [...]
Read more
Category "Medical"
Oncology Drug Price Transparency – Impact on Self-Insured Employers
Self-Funded Employer Health Plans Implications of Drug Price Transparency Strategies to Manage Medical Oncology Costs & Improve Care Quality Wes Chapman April 30, 2021 Introduction I [...]
Read more
Oncology Drug Discovery – 5 Years of Translational Success
Oncology Drug Discovery Delivering Translational Excellence & Fulfilling the Promise of Individualized Care March 31, 2021 Wes Chapman Figure 1 Translation: “the process of turning observations [...]
Read more
Nashville Property Tax Increase – A Review of Public Documents
Nashville Property Tax Increase A Review of Public Documents Wes Chapman & Pepper Hatch September 16, 2020 Summary and Conclusions On April 28th, 2020 Metro [...]
Read more
COVID-19; What is Angela Merkel telling us?
COVID-19; What is Angela Merkel telling us? “We have to understand that many people will be infected, … The consensus among [...]
Read more
An analysis of FDA oncology drug approvals – implications for patients and clinical trials
2018/2019 Oncology Drug FDA Approvals Notifications Implications for Early Phase Clinical Trials Dr. Wael Harb & Wes Chapman August 18, 2019 Illustration of an [...]
Read more
Medical Oncology Practice Valuation – Art & Science
Medical Oncology Practice Valuation Art and Science The Oncology Valuation Series November 27, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. “In the short [...]
Read more
EBITDA – The Oncology Valuation Series
EBITDA What is it, and why does it matter? The Oncology Valuation Series November 21, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. My [...]
Read more
240% Growth in Oncology Drug Approvals in 2017; Good News for Cancer Patients
240% Growth in Oncology Drug Approvals in 2017 Good News for Cancer Patients Wes Chapman January 2, 2018 Introduction Advances in medical oncology depend on [...]
Read more
MIPS for Medical Oncology Practices – Strategic Considerations
MIPS/MACRA 2018 Strategic Considerations for Medical Oncology Practices Implications of a Zero Sum Game Wes Chapman December 2017 A Doomsday Solution to a Zero Sum [...]
Read more